Aspen Pharmacare HoldingsJSE:APN +0.71%73 Interest Coverage is 2.22 as of Dec. 2025, which is 56% below its 10-year median of 5.01. GuruFocus rates JSE:APN with a GF Score™ of 73/100 and a GF Value™ of R178.17 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 684 Drug Manufacturers companies, Aspen Pharmacare Holdings ranks worse than 73.39% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Aspen Pharmacare Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was R1,820 Mil. Aspen Pharmacare Holdings's Interest Expense for the
six
months ended in Dec. 2025 was R-820 Mil.
Aspen Pharmacare Holdings's interest coverage for the quarter that ended in Dec. 2025 was 2.22.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Aspen Pharmacare Holdings's Interest Coverage or its related term are showing as below:
JSE:APN'
s Interest Coverage Range Over the Past 10 Years
Min: 3.88 Med: 5.01 Max: 11.49
Current: 4.35
JSE:APN's Interest Coverage is ranked worse than 73.39% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs JSE:APN: 4.35
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Aspen Pharmacare Holdings Interest Coverage Related Terms
Aspen Pharmacare Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
JSE:APN vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Pharmacare Holdings Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Aspen Pharmacare Holdings's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspen Pharmacare Holdings (JSE:APN) has a Interest Coverage of 2.22 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Aspen Pharmacare Holdings and its competitors. This is 56% below median its historical median of 5.01. Over the past decade, Aspen Pharmacare Holdings' Interest Coverage has ranged from 3.88 to 11.49. According to the industry distribution chart, Aspen Pharmacare Holdings ranks #502 out of 684 companies in the Drug Manufacturers industry, placing it in the top 73.4%.
Is Aspen Pharmacare Holdings' Interest Coverage too high?
Aspen Pharmacare Holdings' current Interest Coverage of 2.22 is 56% below median its 10-year median of 5.01. Over the past 10 years, this metric has ranged from a low of 3.88 to a high of 11.49. The Drug Manufacturers industry median Interest Coverage is 12.77. Aspen Pharmacare Holdings' value of 2.22 is 82.6% below this industry median. Based on the distribution chart, Aspen Pharmacare Holdings ranks #502 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aspen Pharmacare Holdings ranks #502 out of 684 companies for Interest Coverage. This places Aspen Pharmacare Holdings in the lower half of its industry. The industry median Interest Coverage is 12.77. Aspen Pharmacare Holdings' value of 2.22 is 82.6% below this benchmark. Historically, Aspen Pharmacare Holdings' own Interest Coverage has ranged from 3.88 to 11.49 over the past decade. While the company's 10-year median is 5.01 vs. the industry median of 12.77, Aspen Pharmacare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspen Pharmacare Holdings's current Interest Coverage of 2.22 is 82.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Aspen Pharmacare Holdings and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Pharmacare Holdings's current Interest Coverage is 2.22, which is 56% below median its own 10-year median of 5.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.17, compared to a current price of R155.95 — trading 12.5% below its estimated fair value. The current Interest Coverage is 2.22, which is 56% below median its 10-year median of 5.01 and 82.6% below the Drug Manufacturers industry median of 12.77. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current Interest Coverage is 2.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued.
The current stock price of R155.95 is trading 12.5% below its estimated GF Value™ of R178.17.
GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.
Key valuation signals for JSE:APN:
Interest Coverage: 2.22 (56% below median its 10-year median of 5.01)
GF Value™: R178.17 vs. price of R155.95 (12.5% below fair value)
Industry Position: 82.6% below the Drug Manufacturers median (#502 of 684)
No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score
Get the complete analysis for JSE:APN
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:APN has been successfully added to your 
